AuroBlog - Aurous Healthcare Clinical Trials blog

JULY 7, 2022

With an aim to improve the quality of drugs sold in the country, the Union health and family welfare ministry has released 9th edition of Indian Pharmacopoeia (IP) 2022 containing 92 new monographs for drugs, 12 new general chapters, 1,245 monographs for formulations, 930 monographs for active pharmaceutical ingredients (APIs) as well as dissolution (..)

Containment 137

Containment Drugs Clinical Trials Clinical Trials 137

Drug Discovery World

AUGUST 4, 2022

It may seem counterintuitive to spend time and money on planning for containment and delivery systems for a drug in the earliest stages of discovery when the chances of that molecule making it to market are still quite low. The increasing complexity of drug products has raised concern among pharmaceutical developers.

Containment 52

Containment Development Drugs Production 52

Outsourcing Pharma

JANUARY 30, 2024

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Containment 104

Containment Packaging Packaging Drug Delivery 104

Drug Patent Watch

FEBRUARY 9, 2023

Annual Drug Patent Expirations for CARDENE+IN+4.8%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 4.8% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from two… The post New patent for Chiesi drug CARDENE IN 4.8%

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

FEBRUARY 9, 2023

Annual Drug Patent Expirations for CARDENE+IN+5.0%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 5.0% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from two… The post New patent for Chiesi drug CARDENE IN 5.0%

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

FEBRUARY 9, 2023

Annual Drug Patent Expirations for CARDENE+IN+0.86%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.86% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA.

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

FEBRUARY 9, 2023

Annual Drug Patent Expirations for CARDENE+IN+0.83%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA.

Containment 52

Containment Drugs Marketing 52

STAT News

JULY 26, 2022

WASHINGTON – Nearly three quarters of Americans give the pharmaceutical industry credit for helping contain Covid-19 — and for a sector that’s been roundly criticized for nearly a decade, that’s a reason to celebrate.

Containment 98

Containment Nurses Drugs Doctors 98

Bio Pharma Dive

MAY 17, 2022

The company can now resume testing in nearly a dozen studies that were paused due to FDA concerns about interactions between the drug, lenacapavir, and the glass vials in which it was contained.

Manufacturing 273

Manufacturing Drugs Containment 273

Drug Patent Watch

APRIL 13, 2023

Annual Drug Patent Expirations for ZOSYN+IN+PLASTIC+CONTAINER Zosyn In Plastic Container is a drug marketed by Wyeth Pharms and is included in one NDA. There… The post New patent expiration for Wyeth Pharms drug ZOSYN IN PLASTIC CONTAINER appeared first on DrugPatentWatch - Make Better Decisions.

Containment 40

Containment Drugs Marketing 40

Fierce Pharma

MAY 17, 2024

Following a controversy over Covis’ preterm birth drug Makena in the U.S. A committee of the European Medicines Agency on Friday called for the withdrawal of preterm birth drugs containing 17-hydroxyprogesterone caproate (17-OHPC), citing safety and efficacy concerns.

Regulation 106

Regulation Drugs Containment Medicine 106

Roots Analysis

FEBRUARY 28, 2022

Considering patient’s health and safety, the drug products are expected to be free from microbial contamination and should be safe for use throughout the drug’s life cycle. One of the stages that require quality assurance is packaging of the drug product, as compromised packaging could have serious consequences.

Containment 52

Containment Packaging Packaging Contamination 52

Drug Patent Watch

JULY 11, 2021

Annual Drug Patent Expirations for BREVIBLOC+IN+PLASTIC+CONTAINER Brevibloc In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. The post New patent expiration for Baxter Hlthcare drug BREVIBLOC IN PLASTIC CONTAINER appeared first on DrugPatentWatch - Make Better Decisions.

Containment 52

Containment Drugs Marketing 52

Outsourcing Pharma

JANUARY 30, 2024

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Containment 59

Containment Packaging Packaging Drug Delivery 59

Drug Patent Watch

JULY 11, 2021

Annual Drug Patent Expirations for BREVIBLOC+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Brevibloc Double Strength In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from three….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

JANUARY 11, 2021

Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+IN+PLASTIC+CONTAINER Esmolol Hydrochloride In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available from one….

Containment 52

Containment Drugs Marketing 52

Bio Pharma Dive

MARCH 1, 2022

According to Gilead, the agency has concerns about the interaction between an injectable solution of the drug, called lenacapavir, and the vials in which it's contained.

Drugs 177

Drugs Containment 177

Drug Patent Watch

FEBRUARY 25, 2020

Court of Appeals for the Federal Circuit (CAFC) denied a petition to rehear arguments regarding the invalidity of patent claims containing the phrase…. The post 244 Drug Patents With Claims Containing “consisting essentially of” may be Unenforceable appeared first on DrugPatentWatch - Make Better Decisions.

Containment 69

Containment Drugs 69

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+4.8%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 4.8% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. The post New patent for Chiesi drug CARDENE IN 4.8% It is available from two….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+5.0%25+DEXTROSE+IN+PLASTIC+CONTAINER 25+DEXTROSE+IN+PLASTIC+CONTAINER Cardene In 5.0% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. The post New patent for Chiesi drug CARDENE IN 5.0% It is available from two….

Containment 52

Containment Drugs Marketing 52

Pharmaceutical Technology

MAY 10, 2023

Gilead Sciences has emerged victorious in a legal battle with the US government over patents surrounding the HIV pre-exposure prophylaxis (PrEP) drugs Descovy and Truvada following a federal jury’s verdict on May 9. While both Descovy and Truvada contain emtricitabine, they feature different forms of the antiviral tenofovir.

FDA Approval 264

FDA Approval Drugs Containment Licensing 264

Drug Patent Watch

JANUARY 11, 2021

Annual Drug Patent Expirations for ESMOLOL+HYDROCHLORIDE+DOUBLE+STRENGTH+IN+PLASTIC+CONTAINER Esmolol Hydrochloride Double Strength In Plastic Container is a drug marketed by Hq Spclt Pharma and is included in one NDA. It is available….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+0.83%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from….

Containment 52

Containment Drugs Marketing 52

Drug Patent Watch

SEPTEMBER 30, 2020

Annual Drug Patent Expirations for CARDENE+IN+0.86%25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER 25+SODIUM+CHLORIDE+IN+PLASTIC+CONTAINER Cardene In 0.86% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. It is available from….

Containment 52

Containment Drugs Marketing 52

STAT News

JANUARY 9, 2023

Food and Drug Administration commissioner Robert Califf doesn’t disagree with the basic findings of a congressional investigation into the agency’s role in the controversial approval of Aduhelm, Biogen’s first Alzheimer’s drug. SAN FRANCISCO –  U.S.

Containment 134

Containment Drugs 134

Pharmaceutical Technology

APRIL 24, 2023

However, the reality is that traditional medicine has been the source of lead identification in modern drug discovery. Ethnopharmacology has been an important basis for modern medicine The estimated percentage of pharmaceutical drugs available today that are sourced from natural products varies.

Medicine 262

Medicine Drugs Production Research 262

Bio Pharma Dive

FEBRUARY 12, 2024

The failure of CSL’s plasma-derived infusion, which contains a protein in “good” cholesterol, follows a similar path as pills from Lilly, Merck, Pfizer and Roche.

Containment 164

Containment Protein Drugs 164

The Pharma Data

SEPTEMBER 24, 2020

Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new study. The team looked through the National Institute of Health’s Dietary Supplement Label Database and the Natural Medicines Database for products containing unapproved drugs.

Containment 52

Containment Drugs Production Engineer 52

BioTech 365

JULY 20, 2021

Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs In Development, 2021 Research Report – ResearchAndMarkets.com Bromodomain Containing Protein 4 (Protein HUNK1 or BRD4) Drugs In Development, 2021 Research Report – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Bromodomain Containing Protein 4 (Protein (..)

Protein 40

Protein Containment Development Research 40

Pfizer

AUGUST 22, 2022

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion (containing benzyl alcohol), Due To The Potential Presence of Visible Particulates. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Pfizer Drug Safety.

Containment 97

Containment Production Vaccination Vaccine 97

Pfizer

JULY 13, 2022

Hospira Issues A Voluntary Nationwide Recall For One Lot of Propofol Injectable Emulsion, USP (containing benzyl alcohol), Due To The Potential Presence of Visible Particulate. Propofol is an intravenous general anesthetic and sedation drug for use in the induction and maintenance of anesthesia or sedation. Pfizer Drug Safety.

Containment 98

Containment Production Vaccination Vaccine 98

BioTech 365

DECEMBER 17, 2021

Endothelial PAS Domain-Containing Protein 1 Inhibitors – 2021 Pipeline Landscape Report with Insights on 7+ Companies and Drugs – ResearchAndMarkets.com Endothelial PAS Domain-Containing Protein 1 Inhibitors – 2021 Pipeline Landscape Report with Insights on 7+ Companies and Drugs – ResearchAndMarkets.com … Continue reading (..)

Containment 40

Containment Protein Drugs 40

Pharma Mirror

FEBRUARY 18, 2022

By Christopher Weikart, Chief Scientist, SiO2 Materials Science Even though drugs are meant to save lives, the primary packaging used for delivering drug therapies and vaccines may actually be putting us in danger. The pharmaceutical industry works hard to create cutting-edge drugs to save lives and keep people healthy.

Packaging 130

Packaging Packaging Drugs Clinical Trials 130

STAT News

JANUARY 26, 2023

Drugs like Wegovy and Ozempic are rapidly growing in popularity as weight-loss treatments. These medications contain semaglutide, a drug originally formulated to help people with diabetes control their blood sugar but also has shown to have a significant effect on appetite and is now also used for obesity.

Drugs 119

Drugs Containment 119

Fierce Pharma

SEPTEMBER 13, 2023

For decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter. | For decades, hundreds of oral decongestant products containing phenylephrine have been available in the United States over the counter.

Containment 125

Containment Production Drugs 125

World of DTC Marketing

JUNE 6, 2021

SUMMARY: The media headlines promise weight loss for diabetes patients, but Norvo’s new drug is in the same class as other drugs and carries many warnings. Can diabetes patients really stay adherent to a drug for 63 weeks in which 85% of patients report GI side effects and will insurance cover the cost?

Drugs 318

Drugs Cosmetics Production FDA Approval 318

The Pharma Data

NOVEMBER 30, 2020

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. She noted that EWG’s online database has identified more than 2,000 personal care products that contain talc, including more than 1,000 loose or pressed powders that could pose an inhalation risk. MONDAY, Nov. © 2020 HealthDay.

Containment 52

Containment Production Cosmetics Contamination 52